Pharmaceuticals, Biotechnology and Life Sciences
Alignment with FDA on a single, pivotal, 12-week, placebo-controlled, Phase 3 clinical trial to initiate in the second half of…
Primary safety endpoint met as FX-322 was well tolerated Preliminary clinical data suggests improvement on measures of hearing function Company…
NanOlogy may offer an alternative treatment option for patients with bladder cancer Investigational drug, NanoDoce, is injected locally into tumor…
—Independent Data Safety Monitoring Board (DSMB) recommends HERACLES trial to continue without modification— —Patient recruitment in the study continues with…
BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S, a global leader in medical dermatology and Elektrofi, a Boston- based biotechnology company focused on…
— Experienced R&D strategist brings deep expertise in advanced breeding and gene editing technologies — DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc.…
Pixantrone has been available to patients since 2012 following a conditional approval from the European Medicines Agency PARIS–(BUSINESS WIRE)–Servier today…
European Commission has granted marketing authorisation for the first stem cell-based product in animal health Arti-Cell® Forte is a unique…
Expands Scientific Advisory Board with Appointment of Prof. David Spring CAMBRIDGE, England–(BUSINESS WIRE)–Nanna Therapeutics Ltd, a biotechnology company developing novel…
Imeglimin Phase 3 trial (TIMES 1) met its primary and main secondary endpoints Imeglimin Phase 3 TIMES 3 16-week, double-blind,…